Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > SHORT ALERT

<< Previous

Bullboard Posts

Next >>

Post by Flagshipzillaon Oct 11, 2023 7:38pm

113 Views

Post# 35679744

SHORT ALERT

Short MDMA at 11 cents...

it's going down to 5 cents.

The investors in the last PP are getting massacred having paid 30 cents.

Once those shares are released expect a nose dive.

<< Previous

Bullboard Posts

Next >>

Tilray Brands launches health-conscious cannabis drinks